EcoDrugPlus

Cyclin Dependent Kinase 9

Ensembl ID : ENSJJAG00000017219
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSJJAG00000015881
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSJJAG00000022438
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSJJAG00000002991
Gene Symbol: LOC101614465
3 Cross references
207 Possible Orthologues:

Cytochrome P450 3a25-Like

Ensembl ID : ENSJJAG00000013680
Gene Symbol: LOC101595472
2 Cross references
613 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily A, Polypeptide 13

Ensembl ID : ENSJJAG00000020062
Gene Symbol: CYP3A13
1 Cross references
631 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSJJAG00000017517
Gene Symbol: DGAT1
3 Cross references
260 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSJJAG00000011657
Gene Symbol: DHFR
2 Cross references
352 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSJJAG00000004380
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSJJAG00000006583
Gene Symbol: DPP4
3 Cross references
282 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSJJAG00000010116
Gene Symbol: DDR2
3 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSJJAG00000014282
Gene Symbol: DRD1
3 Cross references
261 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).